Organovo Logo (2 Color Med-Res-082117).png
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
02 févr. 2022 12h00 HE | Organovo, Inc.
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that two of its patents have withstood a patent challenge, and the company provided guidance on...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
10 janv. 2022 12h00 HE | Organovo, Inc.
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in...
Organovo Logo (2 Color Med-Res-082117).png
Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022
30 nov. 2021 08h05 HE | Organovo, Inc.
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
17 sept. 2021 16h10 HE | Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
02 mars 2021 08h05 HE | Organovo, Inc.
SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
03 sept. 2020 16h05 HE | Organovo, Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces One-for-Twenty Reverse Stock Split
17 août 2020 08h05 HE | Organovo, Inc.
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Acknowledges Receipt of Proposal
02 oct. 2019 19h31 HE | Organovo, Inc.
SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient Biosciences (“Viscient”), an...
Organovo Logo (2 Color Med-Res-082117).png
Organovo to Explore Strategic Alternatives and Implement Restructuring Plan
07 août 2019 09h00 HE | Organovo, Inc.
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it has engaged Roth Capital Partners (“Roth”) as its financial advisor to assist...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
18 juil. 2019 08h05 HE | Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...